Home > News > Close Brothers Seydler issues 'buy' recommendation for Nanostart and EUR30.8 price target
December 6th, 2010
Close Brothers Seydler issues 'buy' recommendation for Nanostart and EUR30.8 price target
Abstract:
Equity research firm Close Brothers Seydler released a report on nanotechnology investor Nanostart AG on Friday, stating a 'buy' recommendation and a price target of EUR 30.80, nearly double its last closing price.
Frankfurt-based Nanostart invests in emerging nanotechnology companies, both public and private, that span across Europe, Asia and the US. With EUR 35 million invested to date, its current portfolio consists of nine companies across a variety of industries.
"The biggest holding, MagForce, is a shining star of the portfolio, having developed a revolutionary treatment for solid tumor brain cancers. The second largest holding, ItN, is leading the way in water filtration using ceramic treated with nanotechnology," said Close Brothers.
The research firm also noted that Nanostart is partnered with the Singaporean government and works closely in a joint fund to invest in companies out of Asia, giving it a "first-mover advantage".
Source:
proactiveinvestors.com.au
Bookmark:
| Related News Press |
News and information
Sensors innovations for smart lithium-based batteries: advancements, opportunities, and potential challenges August 8th, 2025
Deciphering local microstrain-induced optimization of asymmetric Fe single atomic sites for efficient oxygen reduction August 8th, 2025
Lab to industry: InSe wafer-scale breakthrough for future electronics August 8th, 2025
Investments/IPO's/Splits
Daikin Industries becomes OCSiAl shareholder July 27th, 2021
INBRAIN Neuroelectronics raises over €14M to develop smart graphene-based neural implants for personalised therapies in brain disorders March 26th, 2021
180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021
Nanomedicine
New molecular technology targets tumors and simultaneously silences two ‘undruggable’ cancer genes August 8th, 2025
New imaging approach transforms study of bacterial biofilms August 8th, 2025
Cambridge chemists discover simple way to build bigger molecules – one carbon at a time June 6th, 2025
Electrifying results shed light on graphene foam as a potential material for lab grown cartilage June 6th, 2025
Announcements
Sensors innovations for smart lithium-based batteries: advancements, opportunities, and potential challenges August 8th, 2025
Deciphering local microstrain-induced optimization of asymmetric Fe single atomic sites for efficient oxygen reduction August 8th, 2025
Japan launches fully domestically produced quantum computer: Expo visitors to experience quantum computing firsthand August 8th, 2025
ICFO researchers overcome long-standing bottleneck in single photon detection with twisted 2D materials August 8th, 2025
Financial Reports
Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021
Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021
Water
Taking salt out of the water equation October 7th, 2022
Nanobiotechnology
New molecular technology targets tumors and simultaneously silences two ‘undruggable’ cancer genes August 8th, 2025
New imaging approach transforms study of bacterial biofilms August 8th, 2025
Ben-Gurion University of the Negev researchers several steps closer to harnessing patient's own T-cells to fight off cancer June 6th, 2025
Electrifying results shed light on graphene foam as a potential material for lab grown cartilage June 6th, 2025
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||